EWSR1 Gene Ewing’s Sarcoma Test
Comprehensive Genetic Analysis for Sarcoma Diagnosis
The EWSR1 Gene Ewing’s Sarcoma Test represents a critical advancement in molecular oncology diagnostics, providing definitive identification of genetic abnormalities associated with Ewing’s sarcoma family tumors. This specialized test utilizes cutting-edge Fluorescence In Situ Hybridization (FISH) technology to detect specific chromosomal translocations that are hallmark features of this aggressive cancer type.
What Does the EWSR1 Test Measure?
This sophisticated genetic test specifically targets and identifies:
- EWSR1 gene rearrangements and translocations
- Chromosomal abnormalities on chromosome 22q12
- Fusion genes resulting from specific translocations
- Genetic markers diagnostic for Ewing’s sarcoma family tumors
The test analyzes paraffin-embedded tumor tissue blocks to detect the presence of characteristic genetic alterations that define Ewing’s sarcoma, primitive neuroectodermal tumors (PNET), and related malignancies.
Who Should Consider EWSR1 Gene Testing?
Clinical Indications and Symptoms
This test is recommended for individuals presenting with:
- Unexplained bone pain, particularly in long bones or pelvis
- Suspicious soft tissue masses or tumors
- Radiographic findings suggestive of bone tumors
- Previous inconclusive biopsy results requiring molecular confirmation
- Family history of sarcoma or genetic cancer syndromes
- Young adults and children with suspicious lesions
Key Benefits of EWSR1 Genetic Testing
Comprehensive Diagnostic Advantages
- Accurate Diagnosis: Provides definitive molecular confirmation of Ewing’s sarcoma
- Treatment Guidance: Informs targeted therapy decisions and treatment protocols
- Prognostic Information: Helps predict disease behavior and treatment response
- Differential Diagnosis: Distinguishes Ewing’s sarcoma from other bone and soft tissue tumors
- Early Detection: Enables prompt intervention and improved outcomes
Understanding Your Test Results
Interpreting EWSR1 Genetic Findings
Your test results will provide clear genetic information:
- Positive Result: Indicates presence of EWSR1 gene rearrangement, confirming Ewing’s sarcoma diagnosis
- Negative Result: Suggests absence of characteristic genetic alterations
- Inconclusive Result: May require additional testing or sample re-evaluation
All results are accompanied by detailed interpretation from our board-certified molecular pathologists, ensuring comprehensive understanding of your genetic profile and its clinical implications.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $190 |
| Regular Price | $250 |
Important Pre-Test Information
The EWSR1 Gene Ewing’s Sarcoma Test requires a physician’s prescription for diagnostic purposes. Please note that prescriptions are not applicable for surgical planning, pregnancy-related cases, or individuals planning international travel. Our standard turnaround time is 7-8 days from sample receipt.
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including:
- New York City and surrounding regions
- Los Angeles and Southern California
- Chicago and Midwest locations
- Houston, Dallas, and Texas facilities
- Miami, Orlando, and Florida centers
- Philadelphia, Boston, and Northeast clinics
Take Action for Your Health Today
Don’t wait to get the answers you need for accurate cancer diagnosis and treatment planning. Our experienced genetic counselors and oncology specialists are ready to assist you with comprehensive EWSR1 testing and personalized care.
Call us now at +1(267) 388-9828 to schedule your EWSR1 Gene Ewing’s Sarcoma Test or to speak with our genetic specialists about your testing needs.
Early genetic detection can make a significant difference in treatment outcomes and quality of life. Trust General Genetics Corporation for reliable, accurate, and timely genetic testing services.
